A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2006
10/18/2006	EP1712237A2 Erythropoietin solution preparation stabilized with leucine, glutamic acid or lysine
10/18/2006	EP1712223A1 Pharmaceutical preparation of recombinant factor VIII lyophilized without albumin as a stabilizer
10/18/2006	EP1712220A1 Pharmaceutical aerosol composition
10/18/2006	EP1711635A1 Genes associated with canine osteoarthritis and related methods and compositions
10/18/2006	EP1711610A2 HETERODIMERIC FOLLICLE STIMULATING HORMONE-Fc (FSH-Fc) FUSION PROTEINS FOR THE TREATMENT OF INFERTILITY
10/18/2006	EP1711609A1 Polynucleotides and polypeptides isolated from lactobacillus rhamnosus hn001 materials incorporating them and methods for using them
10/18/2006	EP1711608A1 Differentiation regulating agent containing gene which regulating differentiation from stem cells into natural killer cells as effective ingredient
10/18/2006	EP1711606A2 Modulation of glucocorticoid receptor expression
10/18/2006	EP1711532A2 Combined use of a glp-1 agonist and gastrin compounds
10/18/2006	EP1711531A2 Neutralizing antibodies and methods of use thereof
10/18/2006	EP1711526A2 Treatment of viral infections
10/18/2006	EP1711523A1 Analogues of glp-1
10/18/2006	EP1711522A2 Antiviral compositions which inhibit paramyxovirus infection
10/18/2006	EP1711518A2 Chimpanzee adenovirus vaccine carriers
10/18/2006	EP1711515A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
10/18/2006	EP1711509A2 Inhibition of bright function as a treatment for excessive immunoglobulin production
10/18/2006	EP1711208A2 Conjugates of amyloid proteins as vaccines for amyloid-related diseases
10/18/2006	EP1711202A1 Treatment of bone metastases by means of pth receptor agonists
10/18/2006	EP1711201A2 Use of low-dose erythropoietin for stimulating endothelial precursor cells, regenerating organs, and slowing down progression of end organ damages
10/18/2006	EP1711200A2 Type ii diabetes
10/18/2006	EP1711199A2 Biotherapeutics, diagnostics and research reagents
10/18/2006	EP1711198A2 Methods and compositons for treating cancer
10/18/2006	EP1711197A1 Methods and compositions for the prevention and treatment of inflammatory diseases or conditions
10/18/2006	EP1711196A2 Inhibitors of type 2 vascular endothelial growth factor receptors
10/18/2006	EP1711187A2 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation
10/18/2006	EP1711174A1 Adjuvant compositions
10/18/2006	EP1711163A2 Dispersions prepared by use of self-stabilizing agents
10/18/2006	EP1711159A1 Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of active agents, preferably a gnrh
10/18/2006	EP1641421A4 Methods and apparatus for creating particle derivatives of hdl with reduced lipid content
10/18/2006	EP1578768A4 Novel peptide dimers as agonists of the erythropoietin (epo) receptor, and associated methods of synthesis and use
10/18/2006	EP1448595B1 Antimicrobial polypeptides from pseudoplectania nigrella
10/18/2006	EP1389236B1 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof
10/18/2006	EP1358332B1 A serpin in bifidobacteria
10/18/2006	EP1337636B1 Soluble zcytor 11 cytokine receptors
10/18/2006	EP1332206B1 Recombinant alpha-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
10/18/2006	EP1246649B1 Intravascular delivery of nucleic acid
10/18/2006	EP1212352B1 Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1
10/18/2006	EP1208196B1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/18/2006	EP1200588B1 Single-chain polypeptides comprising troponin i n-terminal fragments and troponin c
10/18/2006	EP1194554B1 Delivery of trefoil peptides
10/18/2006	EP1180039B1 Composition for the treatment of a neurological disorder
10/18/2006	EP1165778B1 Uses of casb618 polynucleotides and polypeptides
10/18/2006	EP1141286B1 Cytokine receptor chain
10/18/2006	EP1131434B1 Apoptosis-inducing factor
10/18/2006	EP1127126B1 G-protein coupled receptors, homologous to ebv-induced gpcr 2 (ebi-2). methods to seek for ligands thereof
10/18/2006	EP1119611B1 Composition for use in chemonucleolysis
10/18/2006	EP1042468B1 Low-voltage activated calcium channel compositions and methods
10/18/2006	EP1019500B1 Ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons
10/18/2006	EP1007082B1 Modified tumor necrosis factor
10/18/2006	EP1004667B1 Cell cycle-regulating proteins
10/18/2006	EP1003533B1 Use of herpes vectors for tumor therapy
10/18/2006	EP0991661B1 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof
10/18/2006	EP0979239B1 Prevention and treatment of hepatocellular cancer
10/18/2006	EP0969862B1 Synthetic hiv gag genes
10/18/2006	EP0950096B1 Anti-invasive and anti-angiogenic urokinase fragments and their use
10/18/2006	EP0944649B1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
10/18/2006	EP0939828B1 Herpesvirus saimiri as viral vector
10/18/2006	EP0927252B1 Antibodies against interferon alpha/beta receptor
10/18/2006	EP0877756B1 Anti-microbial protein
10/18/2006	EP0797664B1 Use of a human interleukin-11 receptor
10/18/2006	EP0778849B1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
10/18/2006	EP0656788B1 Hla binding peptides and their uses
10/18/2006	CN1849400A Polynucleotides and polypeptides of the erythropoietin gene
10/18/2006	CN1849396A Improved inhibitor nucleic acids
10/18/2006	CN1849395A HLA-a24 binding cancer antigen peptide derived from ribin
10/18/2006	CN1849394A Plasminogen activators having reduced lysine binding capacity
10/18/2006	CN1849391A Nitrilases, nucleic acids encoding them and methods for making and using them
10/18/2006	CN1849333A New antitumoral compounds
10/18/2006	CN1849329A CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses
10/18/2006	CN1849142A 2'-branched nucleosides and flaviviridae mutation
10/18/2006	CN1849141A Spacer moiety for poly(ethylene glycol)-modified peptide- based compounds
10/18/2006	CN1849137A Special reagent for diagnosing and treating disease based on VEFG,HER-2,PSA protein isomer
10/18/2006	CN1849133A Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
10/18/2006	CN1849132A Compounds that modulate neuronal growth and their uses
10/18/2006	CN1849131A Treating immunological disorders using agonists of interleukin-21 / interleukin-21 receptor
10/18/2006	CN1849122A Method of treating cancer using fpt inhibitors and at least two antineoplastic agents
10/18/2006	CN1849114A Topical preparations comprising a hydrophilic carrier and a silicone matrix
10/18/2006	CN1849076A Milk fractions and milk preparations for treating and/or preventing COX-2 mediated diseases
10/18/2006	CN1847265A Human chorionic gonadotropic hormone beta strand carboxyl terminal 37 peptide polymer and its use
10/18/2006	CN1847264A Insulin release promoter factor of rana grahami and its medicinal application
10/18/2006	CN1847263A Protein from snake venom for preventing and treating pyemia
10/18/2006	CN1847261A Cyclic peptides as g-protein-coupled receptor antagonists
10/18/2006	CN1847260A Wheat germ protein depressor peptide desalting process
10/18/2006	CN1847259A Preparation of a therapeutic composition
10/18/2006	CN1846793A Tissue engineering bone and its construction and application
10/18/2006	CN1846790A Injected tissue engineering bone and its constrction and application
10/18/2006	CN1846789A Injected bone repairing material and its prepn and application
10/18/2006	CN1846785A Freeze dried composition containing genetic engineering fusion protein
10/18/2006	CN1846784A Amphioxus PE glucoprotein and its production process
10/18/2006	CN1846783A Compound piracetam-cerebral protein hydrolysate capsule and its prepn
10/18/2006	CN1846718A Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
10/18/2006	CN1846669A Sustained release of peptides from pharmaceutical compositions
10/18/2006	CN1280414C Human antibody heavy chain and light chain variable region gene against SARS-Cov S antigen and polypeptide and use thereof
10/18/2006	CN1280310C Fusion protein with cold proventing and curing function and its encoding gene and use
10/18/2006	CN1280309C Erythropoietin with high specific activity
10/18/2006	CN1280307C Cytotoxin T lymphocyte
10/18/2006	CN1279981C 5-CNAC as oral delivery agent for parathyroid hormone fragments
10/18/2006	CN1279975C Inducer of blood vessel neogenesis
10/18/2006	CN1279974C Technology for preparing capsule of liver cell growth promoting factor
10/18/2006	CN1279973C Injected gel type bone repairing biological active material and its preparing method

1 ... 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 ... 3163